Topaz Maxim, Shafran-Topaz Leah, Bowles Kathryn H
University of Pennsylvania's School of Nursing, Philadelphia, PA, USA.
Perspect Health Inf Manag. 2013 Apr 1;10(Spring):1d. Print 2013.
The International Statistical Classification of Diseases and Related Health Problems (ICD) has undergone a long evolution from its initial inception in the late 18th century. Today, ICD is the internationally recognized classification that helps clinicians, policy makers, and patients to navigate, understand, and compare healthcare systems and services. Currently in the United States, hot debates surround the transition from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). This article presents an analysis of the views of the proponents and opponents of the upcoming change. We also briefly present and analyze the quality of the most frequently cited scientific evidence that underpins the recent debates focusing on two major issues: ICD-10-CM implementation costs and revenue gains and the projected clinical data quality improvement. We conclude with policy and research suggestions for healthcare stakeholders.
《国际疾病及相关健康问题统计分类》（ICD）自18世纪末首次创立以来经历了漫长的演变。如今，ICD是国际公认的分类体系，有助于临床医生、政策制定者和患者了解、理解并比较医疗保健系统和服务。目前在美国，围绕从《国际疾病分类，第九次修订本，临床修订版》（ICD - 9 - CM）向《国际疾病分类，第十次修订本，临床修订版》（ICD - 10 - CM）的转变展开了激烈辩论。本文对即将到来的变革的支持者和反对者的观点进行了分析。我们还简要介绍并分析了最近辩论所依据的最常被引用的科学证据的质量，这些辩论聚焦于两个主要问题：ICD - 10 - CM的实施成本和收益以及预计的临床数据质量改善。我们最后为医疗保健利益相关者提出了政策和研究建议。
